{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-016426","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.401764+00:00","generated_at":"2026-06-10T00:07:08.771990+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aprea Therapeutics updates corporate presentation slide deck; no specific changes disclosed","bullets":["Filed corporate presentation slide deck dated October 2023; title indicates focus on precision oncology and synthetic lethality.","No quantitative updates (e.g., financial results, clinical data) disclosed in the filing or the provided exhibit excerpt.","Given the absence of specific changes, materiality of this update appears low."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-016426","json":"https://secwatch.observer/filing/0001558370-23-016426.json","markdown":"https://secwatch.observer/filing/0001558370-23-016426.md","text":"https://secwatch.observer/filing/0001558370-23-016426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000155837023016426/0001558370-23-016426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000155837023016426/apre-20231013x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:07:08.771990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}